Model‐informed drug development (MIDD) has a long and rich history in infectious
diseases. This review describes foundational principles of translational anti‐infective …

Introduction Tuberculosis requires lengthy multi-drug therapy. Mycobacterium tuberculosis
occupies different tissue compartments during infection, making drug access and …

In the present paper, we formulate novel fractional tuberculosis (TB) model with a
generalized Atangana–Baleanu (GAB) fractional derivative. The parameters in this model …

Imperfect medication adherence remains the biggest predictor of treatment failure for
patients with tuberculosis. Missed doses during treatment lead to relapse, tuberculosis …

Tuberculosis (TB) remains one of the leading causes of death by a communicable agent,
infecting up to one-quarter of the world's population, predominantly in disadvantaged …

In a tumour microenvironment, tumour-associated neutrophils could display two opposing
differential phenotypes: anti-tumour (N1) and pro-tumour (N2) effector cells. Converting N2 …

Host-directed therapies (HDTs) that modulate host–pathogen interactions offer an innovative
strategy to combat Mycobacterium tuberculosis (Mtb) infections. When combined with …

This paper deals with the mathematical analysis of Tuberculosis by using fractal fractional
operator. Mycobacterium TB is the bacteria that causes tuberculosis. This airborne illness …

Ethnopharmacological relevance Asthma is a chronic inflammatory disease, characterized
by airway inflammation, hyperresponsiveness, and bronchial smooth muscle contraction …

Tuberculosis (TB) drug discovery and development has undergone nothing short of a
revolution over the past 20 years. Successful public–private partnerships and sustained …